BETA: Please send your feedback!

REGENXBIO

NAS:RGNX

Biotechnology

$1.67bn
SMALL cap
$46.50 (1.80%)
7.3159%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
website

Headquarters

9712 Medical Center Drive
Suite 100
Rockville, MD 20850

Executives

Name Title Gender
Patrick J. Christmas Senior Vice President & General Counsel Male
Donald J. Hayden, Jr., MBA Chairman Male
Kenneth T. Mills President, Chief Executive Officer & Director Male
Vit Vasista, MBA CFO & Principal Accounting Officer Male
Olivier Danos, PhD Chief Scientific Officer Male
Stephen Yoo, MD Chief Medical Officer Male
Kimberly Sloan Senior Vice President-Human Resources Female
Lynne Fahey McGrath, PhD Vice President-Regulatory Affairs Female
James M. Wilson, MD, PhD Founder null
Rickey Reinhardt, MD, PhD Vice President-Clinical Research & Development null
Jerome W. Jackson, MBA Vice President-Information Technology Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 1

REGENXBIO - Competitors and Related Companies

How REGENXBIO stacks up to its peers in the Biotechnology industry or with competing business segments.

REGENXBIO

NAS:RGNX

Biotechnology

$1.67bn
SMALL cap
$46.50 (1.80%)
7.3159%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…